It's Time to Implement ICH Q9(R1)

In this blog post we'll look into what steps you may need to take to make sure you are compliant with the ICH Q9(R1) guideline.

Bioequivalence Studies: How to Streamline Generic Drug Approval Process

This blog post will give you an overview of bioequivalence studies and some strategies to streamline your generic drug approval process.

Removing Subjectivity in Risk Assessments

In this blog post we explore the topic of minimising the subjectivity in Risk Assessments through Digitalisation of processes.